baber/WOPTO huggingface dataset:
Patent PT-946778-E (PT)
Inventor: LAVIN PHILIP ANTHONY
IPC: C23C4/18
Filed: 1997-11-07
Abstract: A coating consisting of ceramo-metallic material, e.g. WC-Co, is applied to an internal surface of a grid plate by flame spraying. A ceramic slurry is applied and fired to produce a ceramic coating which is partially removed to produce a composite ceramo-metallic and ceramic surface which is then bonded and densified. The coating is in the form of an array of islands. A ceramic slurry may then be applied and fixed to produce a ceramic coating which is partially removed to produce a composite ceramic-metallic and ceramic surface which is then bonded and densified. The ceramic slurry may contain a chromium compound capable of being converted into chromium oxide at temperatures of at least 300{C. The composite surface may then be impregnated with a solution of at least one soluble compound capable of being converted on heating, into an insoluble substance which bonds the coatings. The soluble compound may be selected from chromia and phosphate forming compounds.
Patent PT-913083-E (PT)
Inventor: WIKAN EGIL
IPC: A01K11/00
Filed: 1998-10-30
Abstract: A livestock tag locking system device, comprising a male component (1) and a female component (8), wherein the male component (1) has a face (3) onto which indicia may be applied and a stem (4) equipped with a tip (5). The stem (4) is made of a relatively soft plastic material and the tip (5) is made of a relatively hard plastic material. The female component has a cup portion (11) equipped with a retaining ring (14). The cup portion (11) is made of a relatively soft plastic material and the retaining ring (14) is made of a relatively hard plastic material. The largest external diameter of the tip (5) is greater than the smallest internal diameter of the retaining ring (14). Recesses (16) are formed in the tip (5), into which recesses (16) the material of the stem (4) is designed to penetrate during production. The recesses (16) considerably increase the contact surface of the tip (5) with the material of the stem (4). The retaining ring (14) is embedded in the cup portion (11) and is made having a ring portion (22) having an axial extension component. After the retaining ring (14) has been embedded, the ring portion (22) is radially wholly or partly encased by the material of the cup portion (11), the ring portion (22) being designed so as to be radially bendable, so that the ring portion (22) is bent towards the radially exterior material of the cup portion (11) when the tip (5) is pressed through the retaining ring (14). The object of the locking system is primarily to prevent reuse of the livestock tag and to make it simple to destroy or recycle the tag. <IMAGE>
Patent PT-1007001-E (PT)
Inventor: BADER STEFANO
IPC: A61K31/18
Filed: 1998-02-17
Abstract: Nimesulide topical formulations are provided in the form of liquid crystals. The emulsifier cetylstearyl glycoside is used, and constituents of the lipid phase such as caprylic/capric triglycerides and jojoba oil, consistence factors such as cetylstearyl alcohol. Also disclosed is a process for the preparation thereof. The formulations have advantages such as higher stability, better release and absorption of nimesulide, and a higher bioavailability of the active ingredient.
Patent PT-994728-E (PT)
Title: Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
Inventor: CHAIN DANIEL G
IPC: A61K39/00
Filed: 1998-04-09
Abstract: DNA encoding a recombinant antibody molecule end-specific for an amyloid-² peptide, pharmaceutical compositions thereof, and a method for preventing or inhibiting progression of Alzheimer's Disease by introducing such a DNA molecule into brain cells to express the recombinant antibody molecule and prevent the accumulation of amyloid- ² peptides in the cerebrospinal fluid.
Patent PT-947955-E (PT)
Inventor: BARTON NICHOLAS
IPC: G06T5/40
Filed: 1999-03-31
Abstract: A control point based real time primary custom gamma curve generator for color correction equipment. A separate custom gamma curve generator circuit is provided for each of the RBG and luminance channels. A plurality of control points is provided and stored in a lookup table (LUT) stored in a random access memory (RAM). The control points are set and/or adjusted by the operator or loaded from a prestored set (e.g. a default custom gamma curve). The instantaneous input signal is divided into two portions-a control point address portion comprising the most significant bits (MSBs) of the input signal, and an interpolation address portion comprising the least significant bits (LSBs) of the input signal. The MSBs are used to select a particular control point value stored in RAM. The LSBs are used for interpolation of values with a smooth curve between control points. Also described are various user interfaces for the custom gamma curve generator.
Patent PT-1097210-E (PT)
Inventor: REITER CHRISTIAN
IPC: C07K16/28
Filed: 1999-07-09
Abstract: The present invention relates to a nucleic acid molecule comprising a nucleic acid sequence encoding at least one complementary determining region (CDR) of a variable region of an antibody, said antibody specifically interacting with the extracellular domain of the human zeta-chain, said antibody being obtainable by immunizing a rat with Jurkat cells and subsequently with a conjugate comprising a carrier molecule and a peptide comprising the 11 N-terminal amino acids of a the rat zeta-chain. Preferably, the (poly)peptide encoded by the nucleic acid molecule of the invention is a monospecific or bispecific antibody. The invention also relates to pharmaceutical compositions comprising i. a. the nucleic acid molecule or antibody of the invention as well as to kits comprising the aforementioned compounds. Finally, the invention relates to a method for the determination of zeta-chain or eta-chain expression on NK-cells, T-cells or precursors thereof employing the antibody of the invention.
Patent PT-1139789-E (PT)
Inventor: BENGS HOLGER
IPC: A23K20/163
Filed: 1999-11-30
Abstract: The invention relates to foodstuff and animal feed which contain resistant starch on the basis of water-insoluble linear alpha-1,4-D-glucans. The invention also related to the utilization of resistant starch on the basis of water-insoluble linear alpha-1,4-D-glucans as medicaments.
Patent SG-88987-G (SG)
Title: Improvements in substrate structures
IPC: H01L23/367
Filed: 1987-10-12
Abstract: A semiconductor device substrate which is sintered by a hot-pressing method at a very high temperature and under high pressure has two main faces parallel to each other, and a plurality of wires (2) formed therein to extend therethrough to end at these main faces. Semiconductor pellets (18) are bonded onto one main face, and a plurality of leads (27) are mounted onto the other main face. The substrate is made of silicon carbide containing a small quantity of beryllium, and the wires (2) of zirconium boride. A plate is prepared by preforming a powder of the substrate material and a plurality of wire stripes are printed thereon. A plurality of such plates laid over each other and hot-pressed provide a block which is sliced along planes normal to the wires, so that substrates are fabricated from the slices. Several layers (13, 14) of wiring may be formed on the substrate faces. <IMAGE>
Patent SG-97490-G (SG)
Title: Process for reducing sulfur-containing contaminants in sulfonated hydrocarbons,products derived therefrom,and lubricants and fuels containing same
IPC: C07C301/00
Filed: 1990-12-06
Abstract: Processes of reducing the inorganic sulfur-containing acid and the low equivalent weight organic sulfonic acid content of an acid mass comprising organic sulfonic components and inorganic sulfonating agent contaminants are described. In general, the process comprises the steps of (a) treating the acid mass with ammonia in the presence of water to neutralize the acids in said acid mass and to form a mixture containing the ammonium salts of said acids, (b) allowing separation of the mixture to provide a lower aqueous phase containing water-soluble ammonium salts and an upper phase comprising the oleophilic alcohol and ammonium salts of the organic sulfonic acids, and (c) recovering at least a portion of said upper phase. The efficiency of the reduction of undesirable materials from the acid mass can be increased by subjecting the recovered upper phase to additional water extractions in the presence of the oleophilic alcohol. The ammonium salts of the organic sulfonic acids recovered by the above process can be converted to oil-soluble metal salts by reacting said ammonium salts with a basically reacting metal compound in such amounts and under such conditions as to form metal salts of said organic sulfonic acids. The metals salts prepared in this manner may be neutral metal salts or highly basic metal salts. The neutral and metal basic salts are useful in a variety of applications including lubricants and fuels.
Patent IE-820187-L (IE)
Title: Preparation of isosorbide-5-nitrate
IPC: C07D493/04
Filed: 1982-01-28
Abstract: This invention relates to a process for the production of isosorbide-5-nitrate comprising (a) subjecting an acylation mixture of isosorbide containing varying proportions of isosorbide, isosorbide-2-acylate, isosorbide-5-acylate and/or isosorbide-2,5-diacylate, or pure isosorbide-5-acylate or an equimolar mixture of isosorbide-2,5-diacylate and isosorbide to a transacylation reaction in the presence of a catalyst and removing the isosorbide-2-acylate present from the reaction mixture by fractional distillation; (b) optionally subjecting the separated isosorbide-2-acylate to a further purification step; (c) esterifying the obtained isosorbide-2-acylate with nitric acid; and (d) partially hydrolyzing the obtained isosorbide-2-acylate-5-nitrate.
Patent IE-900214-L (IE)
Title: Alkylated polyethylenimine derivatives, process for their¹preparation, their use as pharmaceuticals and pharmaceutical¹preparations
IPC: A23L3/3535
Filed: 1990-01-19
Abstract: The novel uncrosslinked and crosslinked alkylated polyethyleneimines can be used as hypolipidaemics due to their gallic acid-binding activity.
Patent IE-790600-L (IE)
Title: Automatic equaliser
IPC: H04L25/03
Filed: 1979-08-08
Abstract: The present invention comes within the field of synchronous digital transmission. It provides an automatic variable equalization network (1) equipped with phase-locking means, in which a sign coincidence autocorrelator (30) correlates the polarities of two versions of the equalized signal delayed in relation to each other by tau , an integer multiple of the unit time interval of the transmission. It is used advantageously for equalizing synchronous digital transmission channels in switched telephone or telegraph networks.
[US4243956A]
Patent IE-34531-L (IE)
Title: Evaporating a heat sensitive liquid
IPC: A23G3/34
Filed: 1970-09-15
Abstract: 1280892 Toffee TULLAMORE SA 21 Aug 1970 [17 Sept 1969] 45741/69 Heading A2B [Also in Division B1] Toffee is produced by pumping a mixture of sucrose, glucose, non-fat milk solids, fat, salt and water, at a temperature of about 180F., into a nest of fifty-five horizontal tubes surrounded by a jacket supplied with heating-steam at 100 psi. The tubes have a diameter of 3/16 of an inch and a length of 3 feet. The mixture foams and flows through each tube in less than 1 second, the exit temperature being about 260F. The tubes may be made of glass, stainless steel or copper. The tubes may be provided with direct electrical heating.
[GB1280892A]
Patent IE-33618-L (IE)
Title: Sheet metal joint
IPC: E04B1/32
Filed: 1969-11-06
Abstract: 1,269,247. Containers. GOODYEAR AEROSPACE CORP. 3 Nov., 1969 [29 Nov., 1968], No. 53829/69. Heading B8P. [Also in Division E1] In a joint between a pair of corrugated 12, 14, the edge of one sheet 12 is bevelled to an angle equal to half the angle between the sheets and carries a continuous flange 20 which is fastened to the other sheet. In Fig. 1, both sheets are bevelled and flange 20 is of uniform height. In Fig. 4 (not shown) the edge (44a) of the flange (44) is planar as is the edge (48) of the other sheet (42). Flanges may be provided on both sheets.
[GB1269247A]
Patent IE-39658-L (IE)
Title: N-substituted glycinate pharmaceuticals
IPC: C07C229/36
Filed: 1974-08-07
Abstract: 1434088 N-substituted glycinates SCIENCE UNION ET CIE SOC FRANCAISE DE RECHERCHE MEDICALE 16 Aug 1974 [16 Aug 1973] 38730/73 Heading C2C Novel compounds of Formula I in which R represents a cyclopentyl, cyclohexyl or benzyl radical or a benzyl radical carrying one or more substituents selected from halogen atoms, alkyl and alkoxy radicals each having from 1 to 4 carbon atoms, and methylenedioxy and trifluoromethyl radicals, in the form of racemic mixtures and optical isomers, and acid addition salts, especially physiologically tolerable acid addition salts thereof are prepared by reaction of a compound of formula with a compound of formula Pharmaceutical compositions in conventional forms for oral, rectal or parenteral administration and having anorexigenic activity comprise an above novel compound and a carrier or diluent.
[GB1434088A]
Patent IE-801675-L (IE)
Title: 9-o-methylclavulanic acid
IPC: C07D503/00
Filed: 1980-08-08
Abstract: The present invention provides a process for the preparation of 9-0-methylclavulanic acid or a pharmaceutically acceptable salt or in-vivo hydrolysable ester thereof which process comprises the reaction of a cleavable ester of clavulanic acid with methyl iodide or methyl bromide in dry inert organic solvent in the presence of silver ions and either molecular sieve or calcium sulphate and subsequently: i) converting any cleavable ester group which is not in vivo hydrolysable into a free acid, a pharmaceutically acceptable salt or in vivo hydrolysable ester group; ii) optionally converting any cleavable ester group which is in vivo hydrolysable into a free acid, a pharmaceutically acceptable salt or a different in-vivo hydrolysable ester group.
[EP0024123A1]
Patent IE-821733-L (IE)
Title: Whey product
IPC: A23C21/02
Filed: 1982-07-20
Abstract: A biologically pure culture of the organism Xanthomonas campestris ATCC 31922 is disclosed. 
<??>A process for the prduction of a functionalized dairy whey product characterised in that it comprises:
 a) providing a fermentation broth of whey and glucose; and
 b) fermenting the broth with the organism Xanthomonas campestris ATCC 31922 to produce a functionalized dairy whey product containing a thickening polymer produced by the organism;
 and, optionally,
 c) drying the funtionalized whey product to form a dry functionalized whey product is also disclosed. 
<??>Dairy whey, a waste product of cheese production, may be functionalized by fermentation techniques to produce a funtionalized whey which serves as a thickening agent in the food industry. This simultaneously provides a method for utilizing the whey waste product.
Patent IE-781883-L (IE)
Title: Pyrrolidine derivatives.
IPC: C07D295/10
Filed: 1978-09-18
Abstract: New derivatives of phloroglucinol of formula <IMAGE> where R is H or CH3, and their acid addition salts are disclosed. The compounds of formula I and their non-toxic salts are useful in therapeutics as peripheral vasodilating agents.
[FR2404003A1]
Patent IE-792268-L (IE)
Title: Bottle cap
IPC: B65D53/04
Filed: 1979-11-27
Abstract: The present invention relates to a threaded stopper comprising a capsule made of polypropylene and a seal made of EVA. The end of the capsule is offset to lengthen a truncated funnel which is because of its increased length made more supple. The dish-shaped seal element is retained by the funnel and its lip is turned back against the end of the capsule. The invention finds particular application in the packing industry.
[US4261475A]
Patent IE-782327-L (IE)
Title: Pyridine derivative
IPC: A61K31/44
Filed: 1978-11-24
Abstract: A pyridine derivative having the formula 1,3-dihydro-3-(3',4',5'-trimethoxy-styryl)-6-methyl-7-hydroxy-furo-[3, 4,c]pyridine and therapeutically acceptable salts thereof are disclosed. Also disclosed is a process for the preparation of the compound. The compounds are therapeutically useful for a stabilizing effect on the red blood corpuscles and as selective diuretics.
[US4221795A]
Patent IE-872445-L (IE)
Title: Procedure and data structure for synthesis and¹transformation of logic circuit designs.
IPC: G06F17/50
Filed: 1987-09-11
Abstract: A procedure is described for the synthesis and transformation of a logic circuit design, provided by the designers, into a database capable of being used to fabricate the actual circuit. The procedure involves the use of model instances which represent the use of circuit components. The original model instances can be associated with groups of rules that determine resulting configurations of generally different model instances or groups of model instances. The rules are tested and, in the presence of a 'true' result, a new model instance (or model instances) can replace one or more original model instances in the data base. The rules associated with a model type (or definition) are rules derived by a design model engineer and can include coupled model instances. The rules can be associated with model definitions, as well as model instances. The data structures associated with each model instance indicate the model interface as well as the model interface port and permit a path to followed in the circuit in either the forward or the reverse signal direction. The model instances reside within model definitions which reside with design data in hierarchical form. The rules controlling the synthesis and transformation of the circuit are contained in a separate hierarchy of data structures or knowledge structures to which reference can be made by design data structures.
[EP0262397A2]
Patent IE-862567-L (IE)
Title: Encapsulating compositions
IPC: C08K5/15
Filed: 1986-09-29
Abstract: An encapsulating composition for electronic devices which comprises a polymeric material and a metal ion scavenger selected from A) Calixarene or oxacalixarene derivatives represented by the formula <CHEM> wherein m'+ m'' = 0 - 8 n = 0 - 8 m' >/= 1/2 (m' + m'') 3 </= m' + m'' + n </= 8 if n = 0, m' + m'' >/= 4 R<3> is H, halogen, or hydrocarbyl, aryl, hydrocarbylaryl or a substituted derivative thereof, and R<3> may be the same or different on each aryl group; R<4> is hydrocarbyl, aryl, hydrocarbylaryl, hydrocarbyloxy, aryloxy, or hydrocarbylaryloxy, or a substituted derivative thereof; or <CHEM> wherein R<5> and R<6> which may be the same or different are H, or hydrocarbyl, aryl, hydrocarbylaryl, or a substituted derivative thereof; R<1><5> is H or hydrocarbyl, aryl, hydrocarbylaryl or a substituted derivative thereof; the calixarene or oxacalixarene derivative being present as a compound per se or being bound into the polymer network of the polymeric material; B) Silacrowns represented by the formula <CHEM> wherein R<7> and R<8> which may be the same or different are hydrocarbyl, aryl, hydrocarbylaryl, hydrocarbyloxy, aryloxy, hydrocarbylaryloxy, or a nitrogen-substituted or other substituted derivative thereof; z is 3 - 6 C) Polyalkylene ether glycols and ether derivatives thereof represented by the formula IV, V, VI or VII below: IV R<9>-(R<1><0>-O)q-R<1><1> wherein q is an integer of from 2 to 3000; R<1><0> is a substituted or unsubstituted alkyl residue having 2 to 6 carbon atoms, the (R<1><0>-O) groups containing the same alkyl residue or containing 2 or more different alkyl residues which may be distributed on the chain in a random or block manner; R<1><1> is hydrogen, hydrocarbyl, aryl, hydrocarbylaryl, or a substituted derivative thereof; R<9> is hydroxy, hydrocarbyloxy, aryloxy, hydrocarbylaryloxy or a substituted derivative thereof: <CHEM> wherein R<1><2> is -(R<1><0>-O)q-R<1><1> in which R<1><0>, R<1><1> and q are as defined above; <CHEM> wherein R<1><2> is as defined above; R<1><3> is hydrogen, halogen, or hydrocarbyl, aryl or hydrocarbylaryl or a substituted derivative thereof; and x is an integer from 4 to 8; <CHEM> wherein R<1><0>, R<1><1> and q are as defined above. t
[EP0262910A2]
Patent IE-892570-L (IE)
Title: Process suitable for the production of beer having a low¹alcohol content
IPC: C12G3/08
Filed: 1989-08-10
Abstract: A process for the production of beer with a low alcohol content is described. The process comprises preparing a wort by boiling and adding ascorbic acid to such wort prior, during, or after boiling, so long as the wort remains hot. The process can be employed according to the invention for the production of non-alcoholic beer by the yeast cold contact process, in which yeast recovered from a fermentation process is brought into contact with the wort at a low temperature below 0 DEG  C. As a rule, the non-alcoholic beer produced by this process imparts an unpleasant and bitter aftertaste. By adding ascorbic acid to the boiling wort, the bitter aftertaste is completely eliminated.
Patent IE-882635-L (IE)
Title: Sanitary napkin pad liner
IPC: A61F13/15
Filed: 1988-08-30
Abstract: A napkin pad liner is provided which is designed to be used with a conventional sanitary napkin to provide more rapid fluid take-up and reduced fluid strikeback. The liner includes a cover of a non-wettable, fluid permeable hydrophobic material which covers a thin layer of absorbent fabric. Pressure sensitive adhesive is located on the napkin-facing side of the absorbent fabric. The adhesive is protected prior to use of the liner by a release strip. In a preferred embodiment the liner is embossed with a central channel to promote rapid longitudinal fluid distribution at the time of fluid take-up.
Patent IE-893588-L (IE)
Title: Removal and recovery of sulphur dioxide from gas streams
IPC: B01D53/77
Filed: 1989-11-08
Abstract: Sulphur dioxide is removed from gas streams by contacting the gas stream with an absorbing medium containing less than about 80 wt. % of water and the spent absorbing medium subsequently is regenerated by removing absorbed SO2. The absorbing medium comprises amine salt absorbent having at least two amine groups, at least one of which is a salt and at least one of which has a pKa of about 4.5 to 7.3. The absorption is at a temperature of less than about 60 DEG  C. The spent absorbing medium is regenerated under conditions such that at least one amine group remains in salt form.
Patent IE-893839-L (IE)
Title: Phenoxy and phenylthio, amino substituted benzocycloalkane¹derivatives in the treatment and prevention of¹drug-resistant protozoal infections
IPC: A61K31/49
Filed: 1989-11-30
Abstract: Pharmaceutical compositions comprising antiprotozoal agents in conjunction with a phenoxyamino-substituted benzocycloalkane derivative are effective in the prevention and treatment of a drug-resistant protozoal infection, particularly, drug-resistant malarial infection in humans.
Patent IE-922399-L (IE)
Title: An ex vivo tissue perfusion composition and the use thereof
IPC: A61K31/765
Filed: 1987-05-14
Abstract: "IMPROVED FIBRINOLYTIC COMPOSITION" of the Invention In accordance with the present invention, a composition is provided that is effective in dissolving blood clots and reestablishing and maintaining blood flow through thrombosed coronary or other blood vessels. The fibrinolytic composition of the present invention comprises an enzyme, such as streptokinase, urokinase, tissue plasminogen activator or other fibrinolytic enzyme, and a surface-active copolymer. The surface-active copolymer can be an ethylene oxide-propylene oxide condensation product with the following general formula: HO(C2H4O)b(C3H6O)a(C2H4O)bH wherein a is an integer such that the hydrophobe represented by (C3H6O) has a molecular weight of approximately 950 to 4000, preferably approximately 1750 to 3500, and b is an integer such that the hydrophile portion represented by (C2H4O) constitutes approximately 50% to 90% by weight of the compound.
[CA1297792C]
Patent NO-782851-L (NO)
Title: Stivt plastark.
Inventor: STABLER HOWARD GRAFTON
IPC: B32B5/00
Filed: 1978-08-22
Abstract: "Stivt plastark"